IMPACT - Targeted prostate cancer screening

This is an international prostate cancer screening study for men with inherited BRCA and mismatch repair (MMR) gene mutations who are at increased risk of prostate cancer. Peter Mac coordinates the Australian axis of the study. Australia has recruited one fifth of the entire worldwide cohort to date with Peter Mac the site of the greatest number of Australian recruits

The IMPACT study will determine how best to screen men with these mutations for prostate cancer and to find new screening tools for prostate cancer in this high risk group. 


Cancer Australia 

Principal investigator 

Associate Professor Paul James 

Contact details 

Ms. Phoebe Martin 

  • Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 

Project group 

Project status 

  • Active